ARTICLE | Company News
Elan, Genzyme Transgenics deal
May 29, 2001 7:00 AM UTC
In a second antibody deal between the companies, GZTC will use its transgenic goats to produce an undisclosed ELN antibody. GZTC also is developing ELN’s Antegren natalizumab humanized monoclonal anti...